US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Vitro Biopharma Inc.
Vitro Biopharma Names Chris Furman Chief Executive Officer
July 18, 2022
From
Vitro Biopharma Inc.
Via
AccessWire
Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells(R) to Treat Pitt Hopkins Syndrome, a rare form of Autism
November 17, 2021
From
Vitro Biopharma Inc.
Via
AccessWire
Topics
Regulatory Compliance
Vitro Biopharma Acquires Fitore Nutrition and Infinivive MD, Adding Revenues from Innovative Stem Cell Activation Products and Topical Cosmetic Stem Cell Serums.
August 31, 2021
From
Vitro Biopharma Inc.
Via
AccessWire
Topics
Regulatory Compliance
Vitro Biopharma Signs Multi-Million Dollar Operating Service Contract with European Wellness Biomedical Group.
August 19, 2021
From
Vitro Biopharma Inc.
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Vitro Biopharma Inc. April 30, 2021; 2nd Quarter ended Financial Results of Operations and Shareholder Letter
July 01, 2021
From
Vitro Biopharma Inc.
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance